Schedule 13G ownership disclosure
Tango Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 87583X109
Event date: 2025-06-30
- Filing-level shares
- 6,029,906.00
- Percent of class
- 5.6%
- Woodline Partners LP
Shares: 6,029,906.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003592
- Form type
- SCHEDULE 13G
- Filer
- Tango Therapeutics, Inc.
- CIK
- CIK 1819133
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership